Inhibitor SourceBook™ Second Edition
Inhibitor SourceBook™ Second Edition
Inhibitor SourceBook™ Second Edition
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Index<br />
Alphabetical Index<br />
400W .................................................................................... 0<br />
400W, Immobilized .......................................................... 0<br />
A<br />
A3, Hydrochloride ..............................................9, 29, 33, 43<br />
A77 726 .................................................................................46<br />
AACOCF 3 ..................................................................................93<br />
7-AAG ................................................................................. 49<br />
Ab 40 Fibrillogenesis <strong>Inhibitor</strong> .............................................96<br />
Ab 42 Fibrillogenesis <strong>Inhibitor</strong> I ...........................................96<br />
Ab 42 Fibrillogenesis <strong>Inhibitor</strong> II .........................................96<br />
Ab 42 Fibrillogenesis <strong>Inhibitor</strong> III ........................................96<br />
Ab 42 Fibrillogenesis <strong>Inhibitor</strong> IV ........................................96<br />
ACA ...........................................................................................93<br />
Acetyl- -keto-b-Boswellic Acid,<br />
Boswellia serrata ......................................................82, 9<br />
N-Acetyl-S-farnesyl-L-cysteine ..................................... 44<br />
N-Acetyl-S-geranylgeranyl-L-cysteine (AGGC) ........ 44<br />
Acetyl-Pepstatin ................................................................. 25<br />
Actinomycin D, 7-Amino-...................................................72<br />
Actinomycin D, Streptomyces sp. .....................................72<br />
AdaAhX 3 L 3 VS ........................................................................ 37<br />
AdaLys(bio)AhX 3 L 3 VS ......................................................... 37<br />
Adenosine ............................................................................. 4<br />
Adenosine 3´,5´-cyclic Monophosphorothioate,<br />
2´-O-Monobutyryl-, Rp-Isomer, Sodium Salt .........34<br />
Adenosine 3´,5´-cyclic Monophosphorothioate,<br />
8-Bromo-, Rp-Isomer, Sodium Salt ...........................33<br />
Adenosine 3´,5´-cyclic Monophosphorothioate,<br />
8-Bromo-2´-monobutyryl-, Rp-Isomer,<br />
Sodium Salt ......................................................................33<br />
Adenosine 3´,5´-cyclic Monophosphorothioate,<br />
8-Chloro-, Rp-Isomer, Sodium Salt ...........................33<br />
Adenosine 3´,5´-cyclic Monophosphorothioate,<br />
Rp-Isomer, Triethylammonium Salt ...........................33<br />
Adenylyl Cyclase Toxins <strong>Inhibitor</strong> .................................. 39<br />
Adenylyl Cyclase Type V <strong>Inhibitor</strong>, NKY80................... 39<br />
ADP-HPD, Dihydrate, Ammonium Salt ............................79<br />
AEBSF, Hydrochloride ........................................................ 25<br />
AEBSF, Immobilized ........................................................... 25<br />
AG 9 ..........................................................................................46<br />
AG 7 ........................................................................................46<br />
AG 8 ........................................................................................46<br />
AG 30 ........................................................................................46<br />
AG 43 ........................................................................................46<br />
AG 82 ........................................................................................46<br />
AG 99 ........................................................................................46<br />
AG 2 ......................................................................................46<br />
AG 26 .....................................................................................25<br />
AG 83 .....................................................................................46<br />
AG 2 3 .....................................................................................46<br />
AG 490 .....................................................................................46<br />
AG 490, m-CF 3 .......................................................................46<br />
AG 494 .....................................................................................47<br />
AG 527 .....................................................................................47<br />
AG 537, Bis-Tyrphostin ........................................................47<br />
AG 538 .....................................................................................47<br />
I-OMe-AG 538 .......................................................................47<br />
AG 555 .....................................................................................47<br />
AG 556 .....................................................................................47<br />
AG 592 .....................................................................................47<br />
AG 825 .....................................................................................47<br />
AG 835 .....................................................................................47<br />
AG 879 .....................................................................................47<br />
AG 957 .....................................................................................47<br />
AG 957, Adamantyl Ester ....................................................47<br />
AG 024 ...................................................................................47<br />
AG 295 ...................................................................................47<br />
AG 296 ...................................................................................48<br />
AG 387 ............................................................................48, 82<br />
AG 433 ...................................................................................48<br />
AG 478 ...................................................................................48<br />
InSolution AG 478 ...........................................................48<br />
AGL 2043 .................................................................................48<br />
AGL 2263 .................................................................................48<br />
Akt <strong>Inhibitor</strong> .............................................................................4<br />
Akt <strong>Inhibitor</strong> II ..........................................................................4<br />
Akt <strong>Inhibitor</strong> III ........................................................................4<br />
Akt <strong>Inhibitor</strong> IV ........................................................................4<br />
InSolution Akt <strong>Inhibitor</strong> IV ................................................4<br />
Akt <strong>Inhibitor</strong> V, Triciribine.....................................................4<br />
Akt <strong>Inhibitor</strong> VI, Akt-in ..........................................................4<br />
Akt <strong>Inhibitor</strong> VII, TAT-Akt-in ................................................4<br />
Akt <strong>Inhibitor</strong> VIII, Isozyme-Selective, Akti- /2 ...............4<br />
InSolution Akt <strong>Inhibitor</strong> VIII, Isozyme-Selective,<br />
Akti- /2 ...............................................................................4<br />
Akt <strong>Inhibitor</strong> IX, API-59CJ-OMe .........................................4<br />
Akt <strong>Inhibitor</strong> X ..........................................................................5<br />
ALLM ............................................................................. 5, 25<br />
ALLN ................................................................... 5, 25, 37<br />
InSolution ALLN ...................................................... 5, 25<br />
Aloisine A.......................................................................... 5, 9<br />
Aloisine, RP 06 ............................................................... 5, 9<br />
Alsterpaullone ................................................................. 5, 9<br />
Alsterpaullone, 2-Cyanoethyl .................................... 5, 9<br />
a-Amanitin, Amanita sp. ....................................................72<br />
Methyl a-Amanitin Oleate .................................................72<br />
Amastatin, Streptomyces sp. ........................................... 25<br />
Amiloride, Hydrochloride ........................................ 4 , 59<br />
3-Aminobenzamide ..............................................................79<br />
e-Amino-n-caproic Acid .................................................. 25<br />
Aminogenistein ......................................................................48<br />
Aminoguanidine, Hemisulfate ......................................... 0<br />
-Amino-2-hydroxyguanidine,<br />
p-Toluenesulfonate ...................................................... 0<br />
5-Aminoisoquinolinone, Hydrochloride ..........................79<br />
4-Amino- ,8-naphthalimide .............................................79<br />
Aminopeptidase N <strong>Inhibitor</strong> ............................................ 26<br />
Aminopurvalanol A ............................................................... 5<br />
AMO 6 8 ...............................................................................95<br />
AMPK <strong>Inhibitor</strong>, Compound C ..............................................5<br />
InSolution AMPK <strong>Inhibitor</strong>, Compound C ...............5, 84<br />
Anacardic Acid .......................................................................73<br />
Angiogenesis <strong>Inhibitor</strong> .........................................................48<br />
Angiotensin II, Human ...................................................... 39<br />
Anisomycin, Streptomyces griseolus ............................. 60<br />
Anthrax Lethal Factor, Recombinant,<br />
Bacillus anthracis............................................................25<br />
Anthrax Lethal Factor Protease <strong>Inhibitor</strong>,<br />
In-2-LF ............................................................................. 3<br />
Anthrax Lethal Factor Protease <strong>Inhibitor</strong> III ................ 3<br />
a -Antichymotrypsin, Human Plasma.......................... 26<br />
Antipain, Dihydrochloride ................................................ 26<br />
Antipain, Hydrochloride ................................................... 26<br />
a 2 -Antiplasmin, Human Plasma .................................... 26<br />
Antithrombin III, Human Plasma ................................... 26<br />
a -Antitrypsin, Human Plasma ............................. 8, 26<br />
Aphidicolin ..............................................................................72<br />
Apicidin, Fusarium sp. ..........................................................73<br />
Apoptosis <strong>Inhibitor</strong> ...............................................................67<br />
Apoptosis <strong>Inhibitor</strong> II, NS3694 ..........................................67<br />
Aprotinin, Bovine, Recombinant, Nicotiana sp.<br />
Animal-Free ................................................................... 26<br />
Aprotinin, Bovine Lung, Crystalline ............................... 26<br />
Aprotinin, Bovine Lung, Solution ................................... 26<br />
Arachidonylserotonin ....................................................88, 9<br />
H-Arg-Gly-Asp-OH ...............................................................70<br />
H-Arg-Gly-Asp-Ser-OH .......................................................70<br />
Aristolochic Acid ...................................................................93<br />
Aromatase <strong>Inhibitor</strong> I ........................................................ 4<br />
ATBI, Synthetic .................................................................... 26<br />
Atractyloside, Dipotassium Salt,<br />
Atractylis gummifera .................................................. 5<br />
Atrial Natriuretic Factor -28, Rat ............................... 4<br />
Aurintricarboxylic Acid .................................................77, 82<br />
Australine, Hydrochloride,<br />
Castanospermum australe......................................... 47<br />
Autocamtide-2 Related <strong>Inhibitor</strong>y Peptide ......................7<br />
Autocamtide-2 Related <strong>Inhibitor</strong>y Peptide II ..................7<br />
Autocamtide-2 Related <strong>Inhibitor</strong>y Peptide II,<br />
Cell-permeable ..................................................................7<br />
Autocamtide-2 Related <strong>Inhibitor</strong>y Peptide,<br />
Myristoylated .....................................................................7<br />
AY 9944................................................................................. 62<br />
5-Aza-2´-Deoxycytidine .....................................................7<br />
-Azakenpaullone ................................................................. 9<br />
3´-Azido-3´-deoxythymidine .............................................80<br />
InSolution AZT, Triphosphate,Tetralithium Salt .........80<br />
B<br />
Bafilomycin A , Streptomyces griseus ................ 0 , 42<br />
Baicalein ..................................................................................9<br />
Bax Channel Blocker ............................................................67<br />
Bax-Inhibiting Peptide, Negative Control ......................67<br />
Bax-Inhibiting Peptide, V5 .................................................67<br />
BAY -7082 ................................................................. 70, 54<br />
InSolution BAY -7082 ................................................ 54<br />
BAY -7085 ................................................................. 70, 54<br />
Bcr-abl <strong>Inhibitor</strong> ....................................................................48<br />
BEC, Hydrochloride ............................................................ 04<br />
Benzamidine, Hydrochloride ........................................... 26<br />
Benzyl-2-acetamido-2-deoxy-a-<br />
D-galactopyranoside ................................................... 47<br />
BER Pathway <strong>Inhibitor</strong> (DNA Base Excision Repair<br />
Pathway <strong>Inhibitor</strong>) ..........................................................77<br />
Bestatin ................................................................................. 26<br />
Bestatin Methyl Ester ....................................................... 26<br />
BHQ ........................................................................................ 42<br />
Bisindolylmaleimide I ...........................................................37<br />
InSolution Bisindolylmaleimide I ...................................37<br />
Bisindolylmaleimide I, Hydrochloride ..............................37<br />
Bisindolylmaleimide II..........................................................37<br />
Bisindolylmaleimide III, Hydrochloride ...........................37<br />
Bisindolylmaleimide IV ........................................................37<br />
Bisindolylmaleimide V..........................................................37<br />
Bisindolylmaleimide <strong>Inhibitor</strong> Set ....................................42<br />
Blasticidin S, Hydrochloride, Streptomyces<br />
griseochromogenes ..................................................... 60<br />
(—)-Blebbistatin .................................................................. 42<br />
(+)-Blebbistatin .................................................................. 42<br />
(±)-Blebbistatin .................................................................. 42<br />
InSolution Blebbistatin, Racemic ................................ 42<br />
Bohemine................................................................................. 5<br />
Bongkrekic Acid, Triammonium Salt ............................. 5<br />
BPDQ .........................................................................................48<br />
BPIQ-I .......................................................................................48<br />
BPIQ-II ......................................................................................48<br />
bpV(bipy) ..................................................................................59<br />
bpV(HOpic) ..............................................................................59<br />
bpV(phen) ................................................................................59<br />
bpV(pic) ....................................................................................59<br />
Bromocriptine Mesylate .................................................... 0<br />
BTS .......................................................................................... 42<br />
Bufalin ................................................................................... 42<br />
2,3-Butanedione 2-Monoxime ....................................... 42<br />
Butein .......................................................................................48<br />
N-(n-Butyl)deoxygalactonojirimycin ............................ 47<br />
N-Butyldeoxynojirimycin, Hydrochloride .................... 47<br />
C<br />
CA-074 .................................................................................. 27<br />
CA-074 Me ........................................................................... 27<br />
Caffeic Acid.......................................................... 9 , 05, 8<br />
Calcineurin Autoinhibitory Peptide ..................................59<br />
Calcineurin Autoinhibitory Peptide,<br />
Cell-permeable ................................................................59<br />
Calmidazolium Chloride .......................................... 42, 57<br />
Calmodulin Binding Domain ................................................7<br />
[Ala 286 ]-Ca 2+ /Calmodulin Kinase II<br />
<strong>Inhibitor</strong> 28 -30 .............................................................7<br />
Ca 2+ /Calmodulin Kinase II <strong>Inhibitor</strong> 28 -309 .................7<br />
Calmodulin Kinase IINtide ....................................................7<br />
Calmodulin Kinase IINtide, Myristoylated .......................7<br />
Calpain Activity Assay Kit, Fluorogenic ........................ 6<br />
Calpain <strong>Inhibitor</strong> III ............................................................ 5<br />
Calpain <strong>Inhibitor</strong> IV ............................................................ 5<br />
Calpain <strong>Inhibitor</strong> V .............................................................. 5<br />
Calpain <strong>Inhibitor</strong> VI ............................................................ 5<br />
Calpain <strong>Inhibitor</strong> X .............................................................. 5<br />
Calpain <strong>Inhibitor</strong> XI ............................................................ 5<br />
Calpain <strong>Inhibitor</strong> XII ........................................................... 5<br />
Calpain <strong>Inhibitor</strong> Set .......................................................... 6<br />
Calpain Substrate II, Fluorogenic ................................... 6<br />
Calpain Substrate III, Fluorogenic .................................. 6<br />
Calpain- Substrate, Fluorogenic ................................... 6<br />
Calpain- Substrate II, Fluorogenic ............................... 6<br />
Calpastatin Peptide............................................................. 5<br />
Calpastatin Peptide, Negative Control .......................... 5<br />
Calpastatin, Human Erythrocytes ................................... 5<br />
66 Orders Phone 800 854 34 7<br />
Calbiochem • <strong>Inhibitor</strong> SourceBook<br />
Fax 800 776 0999<br />
Web www.emdbiosciences.com/calbiochem